Odonate Therapeutics, Inc. announces an Equity Buyback for 20,000,000 shares, representing 51.95% of its issued share capital.
November 17, 2021 at 07:45 am EST
Odonate Therapeutics, Inc. (NasdaqGS:ODT) announces a share repurchase program. Under the program, the company will repurchase up to 20,000,000 shares, representing 51.95% of its outstanding share capital. The shares will be repurchased in order to return capital to stockholders. As of September 30, 2021, the company had 38,500,000 shares in outstanding.